recently published a prospective study, showing the higher diagnostic accuracy of [68Ga]Ga-PSMA-11 PET/CT in men with high-risk primary prostate cancer, as compared to conventional imaging (CT and bone scan) [6], which is as well supported by retrospective studies [7–9]. The gene discussed is FOLH1; the disease is prostate carcinoma.